Suppr超能文献

抗毒蕈碱药物治疗膀胱过度活动症的临床应用概述。

An overview of the clinical use of antimuscarinics in the treatment of overactive bladder.

作者信息

Athanasopoulos Anastasios, Giannitsas Konstantinos

机构信息

Urodynamic Urology Unit, Department of Urology, Medical School, University of Patras, 26500 Patra, Greece.

出版信息

Adv Urol. 2011;2011:820816. doi: 10.1155/2011/820816. Epub 2011 Jun 7.

Abstract

Overactive bladder is a common and bothersome condition. Antimuscarinic agents, as a class, are the cornerstone of medical treatment of overactive bladder. They offer significant improvements in symptoms and patients' quality of life. Antimuscarinics are generally well tolerated with mild and predictable side effects. Available antimuscarinics have small, yet statistically significant, differences in their efficacy and tolerability profiles. In clinical practice, finding the agent that offers the optimum balance of efficacy and side effects for an individual patient remains the major challenge.

摘要

膀胱过度活动症是一种常见且令人困扰的病症。抗毒蕈碱药物作为一类药物,是膀胱过度活动症药物治疗的基石。它们能显著改善症状和患者的生活质量。抗毒蕈碱药物一般耐受性良好,副作用轻微且可预测。现有的抗毒蕈碱药物在疗效和耐受性方面存在微小但具有统计学意义的差异。在临床实践中,为个体患者找到疗效和副作用达到最佳平衡的药物仍然是主要挑战。

相似文献

引用本文的文献

本文引用的文献

1
Antimuscarinic mechanisms and the overactive detrusor: an update.抗毒蕈碱机制与逼尿肌过度活动:更新。
Eur Urol. 2011 Mar;59(3):377-86. doi: 10.1016/j.eururo.2010.11.040. Epub 2010 Dec 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验